进一步了解儿童喘:从出生队列研究中吸取的经验教训
Yuhan Xing1,2,3, Xinmeng Yang3, Zhaoyinqian Li4,5,6
1School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China.
Clinical reviews in allergy & immunology
|February 7, 2024
概括
了解儿童喘需要使用出生队列研究检查跨生命阶段的暴露. 新的队列和协作网络对于制定有效的预防策略来应对不断增加的过敏和喘患病率至关重要.
科学领域:
- 儿科过敏和免疫学
- 环境流行病学环境流行病学
- 公共卫生 公共卫生
背景情况:
- 儿童喘和过敏是普遍存在的慢性疾病,发病率越来越高,特别是在中国等快速发展的地区.
- 了解喘的多因素病因需要调查不同生命阶段的暴露.
- 出生队列研究对于跟踪喘的自然史和识别关键暴露期至关重要.
研究的目的:
- 审查有关喘和过敏性疾病的出生队列研究的现有证据.
- 评估当前出生队列方法的优点和局限性.
- 为未来的出生队列研究提出基本要素,以推进喘研究.
主要方法:
- 对最近的出生队列研究进行系统审查,重点关注儿科喘和过敏.
- 对研究设计,方法和报告结果的分析.
- 评估队列特征和人口代表性.
主要成果:
- 出生队列为暴露和喘发展之间的时间关系提供了宝贵的见解.
- 确定的局限性包括方法的异质性和某些人群的代表性不足.
- 成功队列的关键要素包括标准化数据收集和先进的分析技术.
结论:
- 使用出生队伍进行进一步的研究对于了解喘病因和发病机制至关重要.
- 在研究不足的人群中启动新的队列和培养协作网络是必要的.
- 将研究结果转化为初级预防策略是对抗儿童喘和过敏的迫切未满足的需求.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
403
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298


